Cipla USA, Inc.: Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle
Recall reason: CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit. Recalled by Cipla USA, Inc.. Distribution: Nationwide in the USA. Classification (Class II — potential health risk). Affected lots/NDC/dates: Lot, expiry: Lot 4PB0526, 4PB0527, 4PB0528, exp September-2026; Lot 5PB0173, exp January-2027. Return the recalled medication to the pharmacy where you purchased it for a full refund of the purchase price.
📬 Get email alerts for new Product Recalls & Refunds
Free — we'll email you when new matching opportunities appear. No spam, unsubscribe anytime.
New here? Here's how Reward Opportunity works:
🔔 More Product Recalls & Refunds
Product recalls offering refunds, replacements, or repairs to consumers who purchased the item.
Browse all product recalls & refunds →Not just this one — find everything you qualify for
Our AI scans 8,000+ bounties, settlements, grants, recalls, and paid studies against your profile to rank what you can actually claim.
Get My Free Match Report